While observing that the lack of supplies from foreign shores and no local manufacturing of the covid drug Tocilizumab is completely unacceptable in the pandemic situation, the Delhi High Court on Monday issued slew of directions for its availability in India. A single judge bench comprising of Justice Pratibha M Singh directed the Centre to inform the Court about the stock available...